Crinetics Pharmaceuticals Pre-Tax Income 2017-2024 | CRNX
Crinetics Pharmaceuticals pre-tax income for the twelve months ending September 30, 2024 was $-0.273B, a 37.7% increase year-over-year.
- Crinetics Pharmaceuticals annual pre-tax income for 2023 was $-0.209B, a 28.5% increase from 2022.
- Crinetics Pharmaceuticals annual pre-tax income for 2022 was $-0.163B, a 51.34% increase from 2021.
- Crinetics Pharmaceuticals annual pre-tax income for 2021 was $-0.108B, a 45.83% increase from 2020.